Immune checkpoint expression on HIV-specific CD4+ T cells and response to their blockade are dependent on lineage and function

Summary: Background: Immune checkpoint blockade (ICB) partially reverses the dysfunctional state of antigen-specific T cell in chronic infections. However, its impact on the diverse subsets of CD4+ T cells in humans is largely unknown. Methods: We examined immune checkpoint (IC) expression and func...

Full description

Bibliographic Details
Main Authors: Elsa Brunet-Ratnasingham, Antigoni Morou, Mathieu Dubé, Julia Niessl, Amy E. Baxter, Olivier Tastet, Nathalie Brassard, Gloria Ortega-Delgado, Roxanne Charlebois, Gordon J. Freeman, Cécile Tremblay, Jean-Pierre Routy, Daniel E. Kaufmann
Format: Article
Language:English
Published: Elsevier 2022-10-01
Series:EBioMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396422004364
_version_ 1811271414284550144
author Elsa Brunet-Ratnasingham
Antigoni Morou
Mathieu Dubé
Julia Niessl
Amy E. Baxter
Olivier Tastet
Nathalie Brassard
Gloria Ortega-Delgado
Roxanne Charlebois
Gordon J. Freeman
Cécile Tremblay
Jean-Pierre Routy
Daniel E. Kaufmann
author_facet Elsa Brunet-Ratnasingham
Antigoni Morou
Mathieu Dubé
Julia Niessl
Amy E. Baxter
Olivier Tastet
Nathalie Brassard
Gloria Ortega-Delgado
Roxanne Charlebois
Gordon J. Freeman
Cécile Tremblay
Jean-Pierre Routy
Daniel E. Kaufmann
author_sort Elsa Brunet-Ratnasingham
collection DOAJ
description Summary: Background: Immune checkpoint blockade (ICB) partially reverses the dysfunctional state of antigen-specific T cell in chronic infections. However, its impact on the diverse subsets of CD4+ T cells in humans is largely unknown. Methods: We examined immune checkpoint (IC) expression and function in HIV-specific CD4+ T cells of viremic individuals (≥5000 vRNA cp/ml, n = 17) prior to ART and persons with spontaneous (n = 11) or therapy-induced (n = 16) viral suppression (<40 cp/ml). We investigated IC patterns associated with exhaustion-related transcription factors and chemokine receptors using activation-induced marker assays. We determined effector functions representative of TFH, TH1, and TH17/TH22 using RNA flow cytometric fluorescence in situ hybridization (FISH). We compared increase in cytokine expression upon ICB across functions and patient status. Findings: Expression of dysfunction-related molecules, such as transcription factors and ICs PD-1, TIGIT, and CD200, followed a hierarchy associated with infection status and effector profile. In vitro responsiveness to PD-L1 blockade varied with defined functions rather than IC levels: frequencies of cells with TH1- and TH17/TH22-, but not TFH-related functions, increased. Cells co-expressing TH1 and TFH functions showed response to ICB, suggesting that the cell's state rather than function dictates responsiveness to PD-L1 blockade. Response to PD-L1 blockade was strongest in viremic participants and reduced after ART initiation. Interpretation: Our data highlight a polarization-specific regulation of IC expression and differing sensitivities of antigen-specific T helper subsets to PD-1-mediated inhibition. This heterogeneity may direct and constrain ICB efficacy in restoring CD4+ T cell function in HIV infection and other diseases. Funding: NIH, CIHR, CFI, FRQS
first_indexed 2024-04-12T22:20:38Z
format Article
id doaj.art-5afb9923fb4d41e4805be2e33fee7a57
institution Directory Open Access Journal
issn 2352-3964
language English
last_indexed 2024-04-12T22:20:38Z
publishDate 2022-10-01
publisher Elsevier
record_format Article
series EBioMedicine
spelling doaj.art-5afb9923fb4d41e4805be2e33fee7a572022-12-22T03:14:23ZengElsevierEBioMedicine2352-39642022-10-0184104254Immune checkpoint expression on HIV-specific CD4+ T cells and response to their blockade are dependent on lineage and functionElsa Brunet-Ratnasingham0Antigoni Morou1Mathieu Dubé2Julia Niessl3Amy E. Baxter4Olivier Tastet5Nathalie Brassard6Gloria Ortega-Delgado7Roxanne Charlebois8Gordon J. Freeman9Cécile Tremblay10Jean-Pierre Routy11Daniel E. Kaufmann12Research Centre of the Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada; Université de Montréal, Montreal, Quebec, CanadaResearch Centre of the Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada; Université de Montréal, Montreal, Quebec, CanadaResearch Centre of the Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, CanadaResearch Centre of the Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada; Université de Montréal, Montreal, Quebec, CanadaResearch Centre of the Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada; Université de Montréal, Montreal, Quebec, CanadaResearch Centre of the Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, CanadaResearch Centre of the Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, CanadaResearch Centre of the Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, CanadaResearch Centre of the Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, CanadaDepartment of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USAResearch Centre of the Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada; Université de Montréal, Montreal, Quebec, CanadaChronic Viral Illnesses Service and Division of Hematology, McGill University Health Centre, Montreal, Quebec, CanadaResearch Centre of the Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada; Université de Montréal, Montreal, Quebec, Canada; Corresponding author.Summary: Background: Immune checkpoint blockade (ICB) partially reverses the dysfunctional state of antigen-specific T cell in chronic infections. However, its impact on the diverse subsets of CD4+ T cells in humans is largely unknown. Methods: We examined immune checkpoint (IC) expression and function in HIV-specific CD4+ T cells of viremic individuals (≥5000 vRNA cp/ml, n = 17) prior to ART and persons with spontaneous (n = 11) or therapy-induced (n = 16) viral suppression (<40 cp/ml). We investigated IC patterns associated with exhaustion-related transcription factors and chemokine receptors using activation-induced marker assays. We determined effector functions representative of TFH, TH1, and TH17/TH22 using RNA flow cytometric fluorescence in situ hybridization (FISH). We compared increase in cytokine expression upon ICB across functions and patient status. Findings: Expression of dysfunction-related molecules, such as transcription factors and ICs PD-1, TIGIT, and CD200, followed a hierarchy associated with infection status and effector profile. In vitro responsiveness to PD-L1 blockade varied with defined functions rather than IC levels: frequencies of cells with TH1- and TH17/TH22-, but not TFH-related functions, increased. Cells co-expressing TH1 and TFH functions showed response to ICB, suggesting that the cell's state rather than function dictates responsiveness to PD-L1 blockade. Response to PD-L1 blockade was strongest in viremic participants and reduced after ART initiation. Interpretation: Our data highlight a polarization-specific regulation of IC expression and differing sensitivities of antigen-specific T helper subsets to PD-1-mediated inhibition. This heterogeneity may direct and constrain ICB efficacy in restoring CD4+ T cell function in HIV infection and other diseases. Funding: NIH, CIHR, CFI, FRQShttp://www.sciencedirect.com/science/article/pii/S2352396422004364HIV-specific CD4+ T cellsT cell dysfunctionImmune checkpoint blockadePD-1TOXCD4+ T cell subsets
spellingShingle Elsa Brunet-Ratnasingham
Antigoni Morou
Mathieu Dubé
Julia Niessl
Amy E. Baxter
Olivier Tastet
Nathalie Brassard
Gloria Ortega-Delgado
Roxanne Charlebois
Gordon J. Freeman
Cécile Tremblay
Jean-Pierre Routy
Daniel E. Kaufmann
Immune checkpoint expression on HIV-specific CD4+ T cells and response to their blockade are dependent on lineage and function
EBioMedicine
HIV-specific CD4+ T cells
T cell dysfunction
Immune checkpoint blockade
PD-1
TOX
CD4+ T cell subsets
title Immune checkpoint expression on HIV-specific CD4+ T cells and response to their blockade are dependent on lineage and function
title_full Immune checkpoint expression on HIV-specific CD4+ T cells and response to their blockade are dependent on lineage and function
title_fullStr Immune checkpoint expression on HIV-specific CD4+ T cells and response to their blockade are dependent on lineage and function
title_full_unstemmed Immune checkpoint expression on HIV-specific CD4+ T cells and response to their blockade are dependent on lineage and function
title_short Immune checkpoint expression on HIV-specific CD4+ T cells and response to their blockade are dependent on lineage and function
title_sort immune checkpoint expression on hiv specific cd4 t cells and response to their blockade are dependent on lineage and function
topic HIV-specific CD4+ T cells
T cell dysfunction
Immune checkpoint blockade
PD-1
TOX
CD4+ T cell subsets
url http://www.sciencedirect.com/science/article/pii/S2352396422004364
work_keys_str_mv AT elsabrunetratnasingham immunecheckpointexpressiononhivspecificcd4tcellsandresponsetotheirblockadearedependentonlineageandfunction
AT antigonimorou immunecheckpointexpressiononhivspecificcd4tcellsandresponsetotheirblockadearedependentonlineageandfunction
AT mathieudube immunecheckpointexpressiononhivspecificcd4tcellsandresponsetotheirblockadearedependentonlineageandfunction
AT julianiessl immunecheckpointexpressiononhivspecificcd4tcellsandresponsetotheirblockadearedependentonlineageandfunction
AT amyebaxter immunecheckpointexpressiononhivspecificcd4tcellsandresponsetotheirblockadearedependentonlineageandfunction
AT oliviertastet immunecheckpointexpressiononhivspecificcd4tcellsandresponsetotheirblockadearedependentonlineageandfunction
AT nathaliebrassard immunecheckpointexpressiononhivspecificcd4tcellsandresponsetotheirblockadearedependentonlineageandfunction
AT gloriaortegadelgado immunecheckpointexpressiononhivspecificcd4tcellsandresponsetotheirblockadearedependentonlineageandfunction
AT roxannecharlebois immunecheckpointexpressiononhivspecificcd4tcellsandresponsetotheirblockadearedependentonlineageandfunction
AT gordonjfreeman immunecheckpointexpressiononhivspecificcd4tcellsandresponsetotheirblockadearedependentonlineageandfunction
AT ceciletremblay immunecheckpointexpressiononhivspecificcd4tcellsandresponsetotheirblockadearedependentonlineageandfunction
AT jeanpierrerouty immunecheckpointexpressiononhivspecificcd4tcellsandresponsetotheirblockadearedependentonlineageandfunction
AT danielekaufmann immunecheckpointexpressiononhivspecificcd4tcellsandresponsetotheirblockadearedependentonlineageandfunction